Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective studyJudith Favier, Tchao Meatchi, Estelle Robidel, et al.Hormone Research|March 30, 2005
Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiencyJudith Favier, Jean-Jacques Brière, Laurence Strompf, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Unbiased CRISPR Synthetic Lethal Screening for Genetic Vulnerabilities in Succinate Dehydrogenase (SDH)-loss Model of ParagangliomaFatimah J Al Khazal, Michael J Emch, Cristina M de Araujo Correia, et al.BMC Biochemistry|January 30, 2010
Rapid determination of tricarboxylic acid cycle enzyme activities in biological samplesSergio Goncalves, Vincent Paupe, Emmanuel P Dassa, et al.Kidney International|January 16, 2023
New advances in endocrine hypertension: from genes to biomarkersFabio L Fernandes-Rosa, Sheerazed Boulkroun, Bakhta Fedlaoui, et al.Oncotarget|September 9, 2017
Establishment of a mouse xenograft model of metastatic adrenocortical carcinomaAurélie Morin, Carmen Ruggiero, Estelle Robidel, et al.The Journal of Clinical Endocrinology and Metabolism|September 5, 2014
Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgeryCedric Rafat, Franck Zinzindohoue, Anne Hernigou, et al.Endocrine-Related Cancer|February 2, 2026
Comprehensive Analysis of Germline and Somatic SDHA Alterations Reveals Rare Incidental Germline Variants and Prognostic Implications of Somatic Loss in Breast CancerHenriett Butz, Bálint Antal, János Papp, et al.European Journal of Human Genetics : EJHG|June 20, 2013
A MEN1 syndrome with a paragangliomaYvan Jamilloux, Judith Favier, Morgane Pertuit, et al.The American Journal of Pathology|April 23, 2003
Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinomaSébastien Le Jan, Céline Amy, Aurélie Cazes, et al.Pageof 11